Tilray Brands (TLRY) Intangibles (2017 - 2026)
Tilray Brands (TLRY) posted Intangibles of $23.3 million for Q1 2026, up 7.4% on a QoQ basis from $21.7 million in Q4 2025, and down 98.51% year-over-year from $1.6 billion in Q1 2025.
Tilray Brands (TLRY) Intangibles (2017 - 2026) Analysis & Trends
Tilray Brands' Intangibles history runs 10 years deep, the most recent figure standing at $23.3 million for Q1 2026.
- Quarterly Intangibles fell 98.51% year-over-year to $23.3 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $23.3 million (down 98.51% YoY) and the FY2025 annual result came in at $21.4 million, down 97.66% from the prior year.
- Intangibles was $23.3 million for Q1 2026 at Tilray Brands, up from $21.7 million in the prior quarter.
- Across five years, Intangibles topped out at $1.6 billion in Q3 2024 and bottomed at $21.4 million in Q2 2025.
- A 5-year average of $900.2 million and a median of $967.6 million in 2023 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2023 — Intangibles surged 1671.9% — and 2026, when it tumbled 98.51%.
- Tilray Brands' Intangibles stood at $1.2 billion in 2022, then retreated by 21.52% to $953.4 million in 2023, then decreased by 9.1% to $866.6 million in 2024, then slumped by 97.49% to $21.7 million in 2025, then increased by 7.4% to $23.3 million in 2026.
- Business Quant data shows TLRY's Intangibles at $23.3 million in Q1 2026, $21.7 million in Q4 2025, and $33.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 23.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 23.34 Mn |
| Nov 30, 2025 | 21.74 Mn |
| Aug 31, 2025 | 33.84 Mn |
| May 31, 2025 | 21.42 Mn |
| Feb 28, 2025 | 1.57 Bn |
| Nov 30, 2024 | 866.65 Mn |
| Aug 31, 2024 | 1.61 Bn |
| May 31, 2024 | 915.47 Mn |
| Feb 29, 2024 | 1.59 Bn |
| Nov 30, 2023 | 953.42 Mn |
| Aug 31, 2023 | 967.57 Mn |
| May 31, 2023 | 973.79 Mn |
| Feb 28, 2023 | 1.58 Bn |
| Nov 30, 2022 | 1.21 Bn |
| Aug 31, 2022 | 1.59 Bn |
| May 31, 2022 | 1.28 Bn |
| Feb 28, 2022 | 89.20 Mn |
| Nov 30, 2021 | 1.55 Bn |
| Aug 31, 2021 | 1.58 Bn |
| May 31, 2021 | 1.61 Bn |